Over the past decade, novel pathogens causing infections in patients have been identified. Chryseobacterium is one such emerging pathogen that is frequently reported in hospitalized patients. Case reports of bloodstream infections, and pneumonia due to Chryseobacterium spp in cancer patients from different parts of the world are drawing the attention of the clinical community to this bacterium as an emerging threat in patients with malignancies. Besides its propensity to cause serious infection to the immune-compromised patients, the antibiotic-resistant trait is posing a serious challenge, further complicating the clinical management of malignancies. We report a similar experience with the bacterium causing bloodstream infection in a patient with Non-Hodgkin lymphoma. The new automated identification systems have enabled us to identify these relatively uncommon pathogens in our clinical setting and also recognize their role in causing infection in hospitalized patients. Besides the difficulties in the treatment of these antibiotic-resistant pathogens, detecting their source within the healthcare setup remains a challenge for medical professionals.
Chryseobacterium indologenes, Multi-drug Resistant, Malignancy
Share This Article
© The Author(s) 2023. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.